Evidence-Based Care for Managing Oncologic Emergencies in Patients with Cancer

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".

Deadline for manuscript submissions: 15 September 2026 | Viewed by 36

Special Issue Editors


E-Mail Website
Guest Editor
Department of Emergency Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: oncologic emergencies; venous thromboembolism; immunotherapy adverse events; sepsis; machine learning and clinical decision support systems
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Interests: oncologic emergencies; biomarkers; diagnostic tools; prognostic tools; diatetes, obesity and metabolic disease in cancer; adverse effects of cancer therapies
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

With the growing number of patients living with active cancer and cancer survivors, there is a pressing need for timely, evidence-based approaches to diagnosing and treating complex oncologic emergencies caused by cancer itself, antineoplastic therapies, and associated comorbidities.

We are pleased to invite you to contribute to this Special Issue, which aims to advance the recognition, management, and outcomes of acute conditions that are increasingly encountered in patients with cancer in emergency departments and urgent care settings.

For this Special Issue, original research articles and reviews are welcome. The scope includes common and critical conditions that are frequently seen in patients with cancer in emergency departments and urgent care settings. Contributions should explore topics including (but not limited to) metabolic disturbances such as tumor lysis syndrome, infections including sepsis, febrile neutropenia, treatment-related toxicities (with a focus on immune checkpoint inhibitor, CAR-T, and bispecific antibodies toxicities), cancer-related complications such as malignant spinal cord compression and venous thromboembolism, cancer-associated pain, and important communication aspects such as advance care planning and discussions of goals of care.

Moreover, research focused on developing and evaluating innovative technologies—such as machine learning and wearable devices—to enhance the early detection, risk assessment, and individualized treatment of oncologic emergencies is highly encouraged.

I look forward to receiving your contributions.

Dr. Aiham Qdaisat
Prof. Dr. Sai-Ching Jim Yeung
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oncologic emergencies
  • cancer
  • urgent
  • infections
  • adverse events
  • thrombosis
  • febrile neutropenia
  • pain
  • spinal cord compression
  • goals of care

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop